REDI-TEST OPIATES

Enzyme Immunoassay, Opiates

ADVANTAGE DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Advantage Diagnostics Corp. with the FDA for Redi-test Opiates.

Pre-market Notification Details

Device IDK991883
510k NumberK991883
Device Name:REDI-TEST OPIATES
ClassificationEnzyme Immunoassay, Opiates
Applicant ADVANTAGE DIAGNOSTICS CORP. 3573 WESTWIND BLVD. Santa Rosa,  CA  95403
ContactJanis Freestone
CorrespondentJanis Freestone
ADVANTAGE DIAGNOSTICS CORP. 3573 WESTWIND BLVD. Santa Rosa,  CA  95403
Product CodeDJG  
CFR Regulation Number862.3650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-06-02
Decision Date1999-09-15
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.

A PHP Error was encountered

Severity: Core Warning

Message: Module 'zip' already loaded

Filename: Unknown

Line Number: 0

Backtrace: